Concepedia

Author

Bleyer Wa

National Institutes of Health

Also Known As

Bleyer Wa, W A Bleyer, WA Bleyer

20

Publications

955

Citations

15

H-Index

57

Concepts

All Affiliations

National Institutes of Health
BW

About

Bleyer Wa is an author at National Institutes of Health specializing in medicine, pharmacotherapy, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

870

2

Health Sciences

5

5

630

3

Allergy

1

1

82

4

Biomedical Engineering

1

1

35

5

Cell Biology

1

1

40

Bleyer Wa

×

14

Publications

894

Citations

13

H-Index

YearCitations

Neurologic sequelae of methotrexate and ionizing radiation: a new classification.

Bleyer Wa

PubMed

1981

267

Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries.

Bleyer Wa, Poplack Dg

PubMed

1985

164

Neurotoxicities of current leukemia therapy.

Pizzo Pa, Poplack Dg, Bleyer Wa

PubMed

1979

97

Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report.

Chard Rl, William Krivit, Bleyer Wa,

PubMed

1980

82

Current status of intrathecal chemotherapy for human meningeal neoplasms.

Bleyer Wa

PubMed

1977

56

Prognostic implications of blast cell morphology in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.

Miller Dr, Mark Krailo, Bleyer Wa,

PubMed

1985

40

Pharmacokinetic considerations on resistance to anticancer drugs.

Dedrick Rl, Zaharko Ds, RA Bender,

PubMed

1975

35

Potential biologic markers in Burkitt's lymphoma.

Waalkes Tp, Gehrke Cw, Bleyer Wa,

PubMed

1975

30

Improved three-year disease-free survival in osteogenic sarcoma

Bleyer Wa, Haas Je, Polly Feigl,

Journal of Bone and Joint Surgery - British Volume

1982

29

Future development of amifostine in cancer treatment.

Alberts Ds, Bleyer Wa

PubMed

1996

24

Page 1